Diego Orsini

11PUBLICATIONS
62CO-AUTHORS
PainApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomedicineChiropracticClinical social work practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 17, 2026
Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis).

|Jun 27, 2025
Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real-Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy.

Giacomo Caldarola, Annunziata Dattola, Nicoletta Bernardini

|Feb 26, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).

Diego Orsini, Dario Graceffa, Martina Burlando

|Oct 26, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.

Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak

|Feb 27, 2024
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study).

Diego Orsini, Giacomo Caldarola, Annunziata Dattola

|Jan 23, 2024
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS).

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli

Pageof 2

Frequent Collaborators

4 joint publications

Elena Campione

4 joint publications

Annunziata Dattola

3 joint publications

Luigi Gargiulo

3 joint publications

Giacomo Caldarola